07.06.2019 | Mia Bengtström, Senior Advisor, PIF

Welcome to the 3rd Nordic Conference on Pediatric Medicines 8-9 October 2019 in Helsinki

3rd Nordic conference will facilitate and bring forward ideas for discussion in order to accelerate medicine development for children, by providing most appropriate context for new solutions, and updating the current information related to pediatric Clinical Trials.


High-quality care calls for enhanced clinical research

Syöpäsäätiö (Cancer Foundation) and thirty-two other research actors provided the parliamentary groups with their appeal for enhanced medical research.


Pharmaceutical industry’s investments in R&D up over six percent in 2018

In 2018, the R&D investments made by the pharmaceutical industry in Finland grew by over six percent. The aggregate investment of the pharmaceutical industry in research and development in 2018 was over 216 million euro, compared to 201 million euro in the previous year.


Construction of future healthcare is a collaborative effort

We in the pharmaceutical industry want to contribute to medical breakthroughs and ensure that they are exploited in the best interest of the patients. During the operating year 2018, we set the step marks for the future and drafted our new strategy for the years 2019-2021.


Medicines account for smaller share of overall healthcare expenses

Even if the total healthcare expenditure has grown, the share accounted by medicines of the overall healthcare expenses has, by no means, grown but decreased from 18 to 15 percent between the years 2008 and 2016. Instead, novel therapies have a clear impact on the total cost of social welfare and healthcare.

1 2 3 4